Aspects of treatment of lower respiratory tract infections in terms of clinical guidelines of different countries (bronchiolitis, bronchitis, community-acquired pneumonia)

Authors

  • S.O. Kramarov Bogomolets National Medical University, Kyiv, Ukraine,
  • Ye.O. Grechukha Bogomolets National Medical University, Kyiv, Ukraine,

DOI:

https://doi.org/10.22141/2312-413x.7.4.2019.178878

Keywords:

bronchiolitis, bronchitis, community-acquired pneumonia

Abstract

According to the international protocols, the treatment of lower respiratory tract infections has its own characteristics in different countries. In general, only oxygen therapy and proper hydration have sufficient evidence in the treatment of bronchiolitis. Virtually all recommendations indicate that acute bronchitis is a self-limiting condition; diagnosis of protracted bacterial bronchitis is possible taking into account the relevant diagnostic criteria. It is interesting to note the influence of vaccination status in the decision-making approach to the antibiotic treatment of community-acquired pneumonia.

References

Friedman J.N. et al. Bronchiolitis: Recommendations for diagnosis, monitoring and management of children one to 24 months of age. Paediatr Child Health. 2014 Nov. 19(9). 485-491.

Ralston S.L. et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014 Nov. 134(5). e1474-502.

O’Brien S. et al. Australasian bronchiolitis guideline. J. Paediatr. Child Health. 2019 Jan. 55(1). 42-53.

Plint A.C. et al. Epinephrine and dexamethasone in children with bronchiolitis. Pediatric Emergency Research Canada (PERC). N. Engl. J. Med. 2009 May 14. 360(20). 2079-89.

Macfarlane J. et al. Prospectivestudy of the incidence, aetiology and out come of adultlower respiratory tract illness in the community. Thorax. 2001 Feb. 56(2). 109-14.

Chang A.B. et al. Management of Children with Chronic Wet Cough and Protracted Bacterial Bronchitis: CHEST Guideline and Expert Panel Report. Chest. 2017 Apr. 151(4). 884-890.

National Institute for Healthcare and Care Excellence (NICE) guideline 120. Cough (acute): antimicrobial prescribing. February 2019.

Braman S.S. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest. 2006. 129 (1 suppl). 95S-103S.

Kantar A. et al. ERS statement on protracted bacterial bronchitis in children. Eur. Respir. J. 2017 Aug 24. 50(2). pii: 1602139.

Chang A.B. et al. Management of Children With Chronic Wet Cough and Protracted Bacterial Bronchitis: CHEST Guideline and Expert Panel Report. Chest. 2017 Apr. 151(4). 884-890.

Harris M. et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011 Oct. 66 Suppl. 2. ii1-23.

Bradley J.S. et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Disea­ses Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011 Oct. 53(7). e25-76.

Fine M.J. et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med. 1997. 336. 243-250.

Lim W.S. et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003. 58. 377-382.

España P.P. et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 2006. 174. 1249-1256.

Charles P.G. et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin. Infect. Dis. 2008. 47. 375-384.

The Royal Children’s Hospital Melbourne. Clinical Practice Guidelines: Community acquired pneumonia. Last revised December, 2016.

Cao B. et al. Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. Clin. Respir. J. 2018 Apr. 12(4). 1320-1360.

Wiersinga W.J. et al. Management of community-pneumonia in adults: 2016 guideline update from the Dutch Working Partyon Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT). Neth. J. Med. 2018 Jan. 76(1). 4-13.

Athlin S. et al. Management of community-acquired pneumonia in immunocompetent adults: updated Swedish guidelines 2017. Infect. Dis. (Lond). 2018 Apr. 50(4). 247-272.

Lee M.S. et al. Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia. Infect. Chemother. 2018 Jun. 50(2). 160-198.

Boyles T.H. et al. South African guideline for the management of community-acquired pneumonia in adults. J. Thorac. Dis. 2017 Jun. 9(6). 1469-1502.

Downloads

Published

2019-08-01

Issue

Vol. 7 No. 4 (2019)

Section

Review

License

Copyright (c) 2019 ACTUAL INFECTOLOGY

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our edition uses the copyright terms of Creative Commons for open access journals.

Authors, who are published in this journal, agree with the following terms:

  1. The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
  2. Directing  the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
  3. The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
  4. The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
  5. The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
  6. The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
  7. The rights to the article are deemed transferred by the authors to the edition (the publisher) since the moment of the publication of the article in the printed or electronic version of journal.